Latest MED Colombia News
Jul 25, 2018
MedReleaf acquires MED Colombia MedReleaf ( OTCPK:MEDFF ) has acquired MED Colombia SAS for a total consideration of €2.75M in cash. MED Colombia has permit (in Colombia) to cultivate cannabis and produce cannabis oil extracts, along with a library of cannabis genetics. The acquisition provides MedReleaf with the ability to produce low-cost, high-quality raw materials to serve its global supply chain as well as the domestic Colombian medical cannabis market.
MED Colombia Frequently Asked Questions (FAQ)
Where is MED Colombia's headquarters?
MED Colombia's headquarters is located at Address Calle 124 #7-35 Office 701, Bogota.
What is MED Colombia's latest funding round?
MED Colombia's latest funding round is Acquired.
Who are the investors of MED Colombia?
Investors of MED Colombia include MedReleaf.